MultiplexDX joined forces with Slovak band IMT Smile and NGO Liga proti rakovine for a unique campaign
Musician and frontman of IMT Smile, Ivan Tasler, a scientist and founder of biotech company MultiplexDX, Pavol Cekan, and director of the NGO Liga proti rakovine, Eva Kovacova, joined forces to remember the story of a bassist of IMTSmile Peter Bartonik, who succumbed to this insidious disease at the age of 27.
With the campaign ‘Zivot Cloveka,’ they want to raise awareness and appeal to the public about the need to prevent oncological diseases, in whichearly diagnosis can be crucial in saving human life – including yours!
The campaign leaders agree that there is not enough education about in public and more should be done to prevent the loss of lives.
The campaign was launched at the IMT Smile concerts last weekend at Castle.
To find out more about the campaign – go to www.zivotcloveka.sk
About MultiplexDX
MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.
Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter
